W.W. Grainger, Inc. - Q1 2008 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2008. W.W. Grainger, Inc. is the leading broad-line supplier of facilities maintenance products and services in North America. The company operates through three reportable segments: Grainger Branch-based (U.S., Mexico, Puerto Rico, China), Acklands-Grainger (Canada), and Lab Safety Supply, Inc. (direct marketing). As of March 31, 2008, there were 76,507,214 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2008 | Q1 2007 |
|---|---|---|
| Net Sales | $1,661.0 million | $1,546.7 million |
| Gross Profit | $679.9 million | $632.1 million |
| Gross Margin | 40.9% | 40.9% |
| Operating Earnings | $185.8 million | $162.6 million |
| Operating Margin | 11.2% | 10.5% |
| Net Earnings | $114.2 million | $101.8 million |
| Diluted EPS | $1.43 | $1.17 |
| Cash from Operations | $13.3 million | $82.4 million |
| Short-Term Debt | $329.5 million | $102.1 million (Dec 2007) |
| Working Capital | $861.0 million | $974.4 million (Dec 2007) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 7.4% year-over-year, driven by mid-single-digit growth in government and commercial sectors, strategic initiatives (market and product expansion), and foreign exchange. Growth was negatively impacted by approximately 1 percentage point due to the timing of the Easter holiday.
- Profitability: Operating earnings rose 14.3%, outpacing sales growth due to positive operating expense leverage. Net earnings increased 12.2%.
- Cash Flow: Operating cash flow decreased significantly to $13.3 million from $82.4 million in the prior year. This was primarily due to a net use of cash of $136.1 million in operating assets and liabilities, specifically increases in accounts receivable and inventory, and a reduction in other current liabilities (annual profit sharing/bonus payments).
- Debt and Liquidity: Short-term debt increased to $329.5 million (up from $102.1 million at year-end 2007) to fund share repurchases and operating needs. The debt-to-total capitalization ratio rose to 14.6% from 5.0%.
- Share Repurchases: The company repurchased $196.4 million of treasury stock in Q1 2008, compared to $98.7 million in Q1 2007.
Guidance, Outlook, and Risks
- Dividend: The Board declared a quarterly dividend of $0.40 per share (a 14% increase from the prior rate), payable June 1, 2008.
- Capital Expenditures: Q1 2008 capital expenditures were $37.2 million, with $15.0 million allocated to the U.S. market expansion program, which is expected to be completed in 2008.
- Financing: On May 6, 2008, the company entered into a $500 million four-year term loan to pay down short-term debt and fund further share repurchases.
- Legal Proceedings: The Department of Justice (DOJ) is investigating potential non-compliance with a General Services Administration (GSA) contract regarding disclosure obligations and pricing. The company is in discussions with the DOJ; while not expected to have a material adverse effect, an unfavorable resolution could result in material payments.
- Segment Performance:
- Grainger Branch-based: Sales up 5.9%; operating earnings up 9.7%. Growth driven by market expansion and product line additions.
- Acklands-Grainger: Sales up 24.8% (7.0% in local currency); operating earnings up 30.5%.
- Lab Safety: Sales up 3.4% (driven by a 2007 acquisition); operating earnings up 1.3%.
Investor Verification Checklist
- Working Capital Trend: Verify the sustainability of the $113.4 million decrease in working capital and the impact of increased short-term borrowing on liquidity.
- Operating Cash Flow: Analyze the drivers behind the sharp decline in operating cash flow ($82.4M to $13.3M), specifically the increase in receivables and inventory levels.
- Legal Exposure: Monitor the status of the DOJ/GSA investigation and potential financial impact of a settlement or litigation.
- Share Repurchase Impact: Assess the effect of aggressive share buybacks ($196.4M in Q1) on the company's debt profile and future capital flexibility.
- Market Expansion ROI: Track the performance of the U.S. market expansion program phases (currently 80-100% complete) to ensure projected incremental sales growth materializes.